Evelo Biosciences Inc
(OTCPK:EVLO)
$
0.0005
0 (0%)
Market Cap: 9,000.00
Enterprise Value: 16.70 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 Evelo Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022 / 04:20PM GMT
Release Date Price:
$41
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Great. Let's go ahead and get started. Welcome, everyone. This is the fireside chat with Evelo Biosciences. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research. Happy to have with me Leslie Wardwell-Scott, from Business Development from Evelo. Thanks for joining us.
Leslie Wardwell;Scott
Thank you for having us.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Before we get started, I need to read a brief disclosure statement. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
With that, thank you, Leslie, for joining us. Really appreciate it.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot